Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Observational Clinical Study of Anti-AAV Seroprevalence in Subjects With Ornithine Transcarbamylase Deficiency, Glycogen Storage Disorder Type Ia, and Wilson Disease

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04909346
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:07.571537+00:00
Published At
2023-06-12T00:00:00+00:00
Record Updated At
2023-06-12
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Ornithine Transcarbamylase Deficiency", "Wilson Disease", "Glycogen Storage Disease Type IA"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-06-12"
protocolSection.identificationModule.nctId
"NCT04909346"
protocolSection.identificationModule.officialTitle
"Observational Clinical Study of Anti-AAV Seroprevalence in Subjects With Ornithine Transcarbamylase Deficiency, Glycogen Storage Disorder Type Ia, and Wilson Disease"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Ornithine Transcarbamylase Deficiency (protocolSection.conditionsModule.conditions)
  • Wilson Disease (protocolSection.conditionsModule.conditions)
  • Glycogen Storage Disease Type IA (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.